Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study

Maturitas

Volumn 63, Issue 1, 2009, Pages 73-78

  Pentti, Kati ^a   Tuppurainen, Marjo T ^a,b   Honkanen, Risto ^b   Sandini, Lorenzo ^a,b   Kröger, Heikki ^a,b   Alhava, Esko ^b   Saarikoski, Seppo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Calcium; CHD; Morbidity; Population based

Indexed keywords

CALCIUM; VITAMIN D;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; POSTMENOPAUSE; PROSPECTIVE STUDY; QUESTIONNAIRE;

CALCIUM; CORONARY DISEASE; DIETARY SUPPLEMENTS; FEMALE; FINLAND; HUMANS; MIDDLE AGED; ODDS RATIO; OSTEOPOROSIS, POSTMENOPAUSAL; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; VITAMIN D;

EID: 67349260046     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.03.006     Document Type: Article

References (43)

1. Griffith L.E., Guyatt G.H., Cook R.J., Bucher H.C., and Cook D.J. The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials. Am J Hypertens 12 January (1 (Pt 1)) (1999) 84-92
2. Bucher H.C., Cook R.J., Guyatt G.H., et al. Effects of dietary calcium supplementation on blood pressure. A meta-analysis of randomized controlled trials. JAMA 275 April (13) (1996) 1016-1022
3. Reid I.R., Horne A., Mason B., Ames R., Bava U., and Gamble G.D. Effects of calcium supplementation on body weight and blood pressure in normal older women: a randomized controlled trial. J Clin Endocrinol Metab 90 July (7) (2005) 3824-3829
4. Witteman J.C., Willett W.C., Stampfer M.J., et al. A prospective study of nutritional factors and hypertension among US women. Circulation 80 November (5) (1989) 1320-1327
5. Ascherio A., Rimm E.B., Giovannucci E.L., et al. A prospective study of nutritional factors and hypertension among US men. Circulation 86 November (5) (1992) 1475-1484
6. Dickinson H.O., Nicolson D.J., Cook J.V., et al. Calcium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2 April (2) (2006) CD004639
7. Bolland M.J., Barber P.A., Doughty R.N., et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336 February (7638) (2008) 262-266
8. Bostick R.M., Kushi L.H., Wu Y., Meyer K.A., Sellers T.A., and Folsom A.R. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 149 January (2) (1999) 151-161
9. Iso H., Stampfer M.J., Manson J.E., et al. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 30 September (9) (1999) 1772-1779
10. Knox E.G. Ischaemic-heart-disease mortality and dietary intake of calcium. Lancet 1 June (7818) (1973) 1465-1467
11. Causes of Death. Helsinki: Statistics Finland, 2002 (www.statfin.-stat.fi/statweb/health/causes of death 1969-2003).
12. Lahti R.A., and Penttila A. The validity of death certificates: routine validation of death certification and its effects on mortality statistics. Forensic Sci Int 115 January (1-2) (2001) 15-32
13. Niemelä H., and Salminen K. Social Security in Finland (2006), The Social Insurance Institution (Kela), The Finnish Centre for Pensions (ETK), The Finnish Pension Alliance (TELA) and The Finnish Ministry of Social Affairs and Health, Helsinki, Finland
14. The Finnish Social Insurance Institution (kela) http://www.kela.fi/in/internet/suomi.nsf/NET/040304095807UK?openDocument [Homepage on the Internet].
15. Grodstein F., Stampfer M.J., Colditz G.A., et al. Postmenopausal hormone therapy and mortality. N Engl J Med 336 June (25) (1997) 1769-1775
16. Barrett-Connor E. Hormone replacement therapy. BMJ 317 August (7156) (1998) 457-461
17. Sourander L., Rajala T., Raiha I., Makinen J., Erkkola R., and Helenius H. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet 352 December (9145) (1998) 1965-1969
18. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288 July (3) (2002) 321-333
19. Wassertheil-Smoller S., Hendrix S.L., Limacher M., et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the women's health initiative-A randomized trial. JAMA 289 May (20) (2003) 2673-2684
20. Rossouw J.E., Prentice R.L., Manson J.E., et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 April (13) (2007) 1465-1477
21. Hsia J., Heiss G., Ren H., et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 115 February (7) (2007) 846-854
22. Prince R.L., Devine A., Dhaliwal S.S., and Dick I.M. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 166 April (8) (2006) 869-875
23. Tuppurainen M., Heikkinen A.M., Penttila I., and Saarikoski S. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3. Maturitas 22 June (1) (1995) 55-61
24. Heikkinen A.M., Tuppurainen M.T., Niskanen L., Komulainen M., Penttila I., and Saarikoski S. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 137 November (5) (1997) 495-502
25. Renaud S., Ciavatti M., Thevenon C., and Ripoll J.P. Protective effects of dietary calcium and magnesium on platelet function and atherosclerosis in rabbits fed saturated fat. Atherosclerosis 47 May (2) (1983) 187-198
26. Yacowitz H., Fleischman A.I., Bierenbaum M.L., and Kritchevsky D. Calcium and lipid metabolism: effects of increased dietary calcium on atherosclerosis in rabbits. Trans NY Acad Sci 33 March (3) (1971) 344-350
27. Dougherty R.M., and Iacono J.M. Effects of dietary calcium on blood and tissue lipids, tissue phospholipids, calcium and magnesium levels in rabbits fed diets containing beef tallow. J Nutr 109 November (11) (1979) 1934-1945
28. Hines T.G., Jacobson N.L., Beitz D.C., and Littledike E.T. Dietary calcium and vitamin D: risk factors in the development of atherosclerosis in young goats. J Nutr 115 February (2) (1985) 167-178
29. Fleischman A.I., Yacowitz H., Hayton T., and Bierenbaum M.L. Long-term studies on the hypolipemic effect of dietary calcium in mature male rats fed cocoa butter. J Nutr 91 February (2) (1967) 151-158
30. Dawson E.B., Frey M.J., Moore T.D., and McGanity W.J. Relationship of metal metabolism to vascular disease mortality rates in texas. Am J Clin Nutr 31 July (7) (1978) 1188-1197
31. Hopkins P.N., and Williams R.R. A survey of 246 suggested coronary risk factors. Atherosclerosis 40 August-September (1) (1981) 1-52
32. Van der Vijver L.P., van der Waal M.A., Weterings K.G., Dekker J.M., Schouten E.G., and Kok F.J. Calcium intake and 28-year cardiovascular and coronary heart disease mortality in Dutch civil servants. Int J Epidemiol 21 February (1) (1992) 36-39
33. Reid I.R., Schooler B.A., Hannan S.F., and Ibbertson H.K. The acute biochemical effects of four proprietary calcium preparations. Aust NZ J Med 16 April (2) (1986) 193-197
34. Pletcher M.J., Tice J.A., Pignone M., and Browner W.S. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 164 June (12) (2004) 1285-1292
35. Block G.A., Spiegel D.M., Ehrlich J., et al. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 68 October (4) (2005) 1815-1824
36. Payne M.E., Anderson J.J.B., and Steffens D.C. Calcium and vitamin D intakes are positively associated with brain lesions in depressed and non-depressed elders. FASEB J 21 April (6) (2007) A1072
37. Chertow G.M., Burke S.K., and Raggi P. Treat to Goal Working Group. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62 July (1) (2002) 245-252
38. Asmus H.G., Braun J., Krause R., et al. Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant 20 August (8) (2005) 1653-1661
39. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 May (20) (2000) 1478-1483
40. Block G.A., Raggi P., Bellasi A., Kooienga L., and Spiegel D.M. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 71 March (5) (2007) 438-441
41. Stevens L.A., Djurdjev O., Cardew S., Cameron E.C., and Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 15 March (3) (2004) 770-779
42. Rasouli M., and Kiasari A.M. Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins. Clin Chem Lab Med 44 1 (2006) 43-50
43. Tang B.M., Eslick G.D., Nowson C., Smith C., and Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370 August (9588) (2007) 657-666